Promoter holding
64.27%
IB
Indfrag Bio Sciences Private Limited - Due diligence report
A 360° intelligence report on Indfragbiosciences: trust score, financial health, credit view, compliance, directors, growth and distress sig…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Indfragbiosciences — 360° Intelligence Report
Generated from MCA filings & public records87/100
Trust Score
Low Risk
Indfragbiosciences is assessed as Low Risk with a Trust Score of 87/100. Indfragbiosciences is an active private limited indian non-government company incorporated in 2015, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 29 Jun 2026 from the latest processed filings. Indfrag Bio Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
87/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 3 open (45.05 cr) · 1 satisfied (8.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 3 | 48.0 cr |
| Dbs Bank Ltd | 1 | 48.0 cr |
Compliance Score: 88/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- 2 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ANITA SAMUEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| FABIAN SAMUEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PHILIP SAMUEL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
3
Group entities
3
Capital events
2 allotment(s) · 2 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Indfrag Asia Pacific Pte Ltd-singapore | Subsidiary Company | 74.00% |
| Indfrag Botaniques Private Limited | Subsidiary Company | 74.00% |
| Sushrut Herbals Private Limited | Subsidiary Company | 74.00% |
| Indfrag Biosciences Inc - Usa | Subsidiary Company | 74.00% |
Key managerial personnel: ANITA SAMUEL (Whole-time director) · FABIAN SAMUEL (Whole-time director) · PHILIP SAMUEL (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 10+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 0.86 in a year.
3 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence81/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 45.05 cr already registered.
- Compliance record supports lending.
Investor view84/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
03 Sep 2020
Charge created
Others - 30.00 Lakh
31 May 2019
Director appointed
FABIAN SAMUEL (Whole-time director)
24 Apr 2019
Charge created
Others - 26.25 cr
02 Jul 2018
Charge satisfied
Dbs Bank Ltd
31 Mar 2018
Share transfer (FY 2018)
496621.00000000 shares to FABIAN SAMUEL
Share transfer (FY 2018)
62500.00000000 shares to FABIAN SAMUEL
22 Mar 2018
Charge created
Others - 18.50 cr
19 May 2017
Securities allotted
80000 Equity Shares - 16.00 Lakh raised
01 Jan 2017
Director ceased
ANITA SAMUEL
Director ceased
PHILIP SAMUEL
28 Oct 2016
Charge created
Dbs Bank Ltd - 8.00 cr
10 Oct 2016
Securities allotted
1910000 Equity Shares - 1.91 cr raised
27 Nov 2015
Incorporated
Registered with Roc Bangalore
10
Key Observations
Auto-generated from the data aboveRevenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 3 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Jipl | U33114KA1994PTC015825 | Bangalore, Karnataka, India |
| Srinivasa Cystine Private Ltd | U24110TG1983PTC003897 | Ap, Telangana, India |
| Marc Laboratories | U72200DL1985PLC020782 | New Delhi, Delhi, India |
| Naveentile | L26914KA1983PLC005401 | Hubli, Karnataka, India |
| Salvichem | U24230MH2005PLC156633 | Mumbai, Maharashtra, India |
| Colorobbia Chemicals India Private Limited | U24121GJ2012FTC070752 | Sanand, Gujarat, India |
| Til Healthcare Private Limited | U24231TN1991PTC020206 | Chennai, Tamil Nadu, India |
| Chemical & Mineral Industries | U14219RJ1972PTC001453 | Jodhpur, Rajasthan, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Indfragbiosciences before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Indfragbiosciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Indfragbiosciences - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Indfragbiosciences pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Indfragbiosciences - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Indfragbiosciences an active company?
Indfragbiosciences has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Indfragbiosciences financially healthy?
Indfragbiosciences has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Indfragbiosciences?
Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Indfragbiosciences?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Indfragbiosciences have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.
Is Indfragbiosciences up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Indfragbiosciences?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
